Picture a founder standing on stage at the Nasdaq. The bell is about to ring. Behind her, a billion dollar valuation. In front of her, institutional investors holding their breath. Three blocks away, another AI founder is signing different papers. No roadshow. No S-1 filing. Just a hundred million dollar check from a strategic buyer who wants the technology, the team, and the competitive advantage, all without the quarterly earnings calls. Same month. Same city. Two radically different exits.
The AI industry is facing its biggest liquidity event in history. Speculation is rampant that a company like OpenAI may eventually pursue an IPO, eyeing a potential $1 trillion valuation after staggering amounts in private funding. Meanwhile, Google just closed its $32 billion acquisition of cloud security firm Wiz, and Meta paid $14.8 billion for a stake in Scale AI.
The question is no longer if AI companies will exit. It's which path captures more value before the window closes.
The mega-IPO wave: Three giants, one narrow window
The potential numbers are staggering. Collectively, market leaders like SpaceX, OpenAI, and Anthropic have raised tens of billions in private capital. This private funding dwarfs the entire US IPO market of recent years, raising questions about market capacity.
For instance, reports from early 2026 speculate that Anthropic's annual revenue run rate could top $30 billion, a dramatic increase from previous years. This kind of growth fuels talk of huge public offerings, but it also highlights a key risk.
Market observers have noted whether these eventual IPOs will jump-start a broader backlog of SaaS and AI names or simply suck a lot of the money and energy out of the room. The risk of concentration is real.
The CoreWeave lesson
CoreWeave priced its March 2025 IPO at $40 per share, raising approximately $1.5 billion, but shares climbed above $100 quickly reaching an excess of $50 billion market capitalisation. The trajectory revealed something critical: AI infrastructure plays command premium valuations when markets recognise their strategic necessity.
Beyond the post-IPO gains, the real story is the signal sent to the sidelines. CoreWeave served as a proof of concept that the IPO market has regained its pulse. Its success can be viewed as the "icebreaker" that may jumpstart a wave of delayed SaaS and AI listings.
This resurgence offers investors a fresh vantage point on AI infrastructure as the public markets warm up.
The M&A surge: Infrastructure over intelligence
While IPO headlines capture attention, M&A tells a different story. In 2025, companies didn't acquire AI models; they acquired the infrastructure that will power autonomous agents for the next decade.
With 33 deals and $157 billion in commitments, enterprises made structural investments in infrastructure, with Google's $32 billion all-cash offer for Wiz representing Google Cloud's most aggressive push to compete with Microsoft and AWS in enterprise security.
Top 5 AI acquisitions of 2025 and early 2026
Acquirer | Target | Value | Strategic intent |
Wiz | $32B | Multi-cloud security visibility | |
Meta | Scale AI (49%) | $14.8B | Human-AI evaluation data for model training |
IBM | Confluent | $11B | Real-time data streaming for agentic AI |
CoreWeave | Core Scientific | $9B | Power infrastructure (1.3 GW capacity) |
Salesforce | Informatica | $8B | Data governance platform |
Sources: Company communication and industry reports
The pattern is unmistakable. Infrastructure wins, real-time data wins, governance wins, and the companies that operationalize AI at scale aren't the ones with the smartest models; they're the ones with the most reliable plumbing.
For investors tracking emerging defense technology players, this infrastructure-first M&A wave signals where strategic value concentrates.
The regulatory wildcard: FTC targets "reverse acquihires"
In early 2026, several US Senators wrote that certain talent acquisition arrangements "further consolidate the Big Tech industry, which in turn could cause higher prices and stifle innovation”.The FTC should not allow companies to avoid typical reviews that apply to acquisitions and mergers.
The race to secure talent in AI drives an increase in "acquihires" where large tech companies buy startups to secure their talent, and "reverse acquihires" where companies recruit top talent without outright acquisition, which are attractive options because Hart-Scott-Rodino Act premerger notification requirements (in the US) do not apply unless an acquiring firm purchases voting securities or assets.
Big Tech has spent tens of billions over two years on these deals to access AI talent and IP without traditional acquisitions, avoiding regulatory filings that can delay closings by 12-18 months. For AI companies considering exit paths, this creates execution risk for M&A that didn't exist 24 months ago.
The dual-track reality: Running both exits simultaneously
Smart AI companies aren't choosing between IPO and M&A. They're running both in parallel.
The dual-track approach allows companies to establish market-clearing price discovery through IPO roadshows while creating competitive tension among strategic buyers who accelerate terms when facing IPO deadlines.
When companies can raise billions privately or go for an acqui-hire, why go public? The answer lies in scale limits, liquidity demands, and strategic validation.
Understanding private equity valuations and exit strategies becomes critical for investors navigating these dual-track processes.
Investment framework: What determines the path
For mega-cap AI companies ($10B+)
Companies with revenue exceeding several billion, clear paths to profitability within 3-5 years, diversified customer bases, and strong governance typically pursue IPOs. Companies with concentrated customers, regulatory overhang, or market timing concerns lean toward M&A.
An example for a typical IPO candidate: Anthropic, which has a strong enterprise revenue mix (reportedly ~80% versus OpenAI's consumer-heavy composition), and enterprise revenue carries higher retention rates, better expansion economics, and lower churn.
For smaller AI companies ($100M-$10B)
Many start-ups are remaining private and pursuing new strategies including reverse acquihires, achieving "centaur" status (over $100M in ARR), tapping into secondary markets, and using continuation funds. They may be choosing "no exit" rather than traditional IPO or M&A routes.
Secondary market transactions have surged as companies seek liquidity without formal exits.
For these companies, M&A isn't just an option; it's often the primary exit path. Valuations can vary widely based on the sub-sector:
- AI developer tools can command around $50M to $500M.
- Enterprise data infrastructure fetches around $500M to $8B.
- Security plays can range from $1B up to the high double-digit billions in major strategic deals.
The outlook: A divided market
IPO window: Open but selective
Coming into 2026, many bankers and issuers were betting on a durable reopening, yet more prospective offerings are being pulled or delayed, making early 2026 much slower than was expected, potentially leaving SpaceX, OpenAI, and Anthropic in a category of their own.
M&A momentum continues
The AI exit landscape in 2026 is not a binary choice. It's a continuous negotiation between public market appetite, strategic buyer intent, regulatory constraints, and founder preferences, all occurring simultaneously.
Companies extracting maximum value treat exit preparation not as a final event but as an ongoing strategic posture. They build enterprise revenue mix commanding public market multiples, establish infrastructure moats that strategic buyers must own, and maintain governance frameworks supporting either path.
For investors, the framework is equally clear: the best AI investments are those where both exit paths yield acceptable returns, and either exit path could yield exceptional returns. Companies with only one viable exit option trade at a discount. Companies with two viable exit options command a premium.
The question isn't which exit. It's which exit, when, and at what valuation.
Published by Samuel Hieber

